Anionic polysaccharides. A class of substances with hepatoprotective and antiadhesive properties in rat liver preservation.
In liver preservation, the substitution of the anion Cl(-) by lactobionic acid (LB) prevents reperfusion edema and extends the preservation time for human livers. We studied the effect of compounds that are structurally related to lactobionic acid: anionic polycarbohydrates (sulfated anionic polysaccharide, SAP, and pentosan polysulfate, PPS) on liver function and leukocyte-endothelial cell interaction in isolated perfusion and liver transplant models. Rat livers, cold-stored (24 h) in a Cl(-) -containing control solution, became edematous during 1 h of reperfusion. Substitution of Cl(-) by either LB, SAP, or PPS decreased reperfusion edema in a Cl(-) concentration-dependent fashion. Reperfusion edema was abolished completely after preservation in 100 mM SAP solution or PPS solution. Also hepatic lactic dehydrogenase (LDH) and aspartate aminotransferase (ASAT) release was lowest after preservation in those solutions. After preservation in LB or anionic polycarbohydrate solutions, portal venous resistance was significantly higher than after preservation in Cl(-)-containing control solution. Capillary blood flow was 391 +/- 83 pl/s and 398 +/- 174 pl/s after preservation in SAP solution (SAPs) and PPSs, and 803 +/- 117 pl/s and 641 +/- 219 pl/s after preservation in LB or Cl(-)-containing control solution. The number of leukocytes sticking to the vascular wall was lower ( P < 0.05) after preservation in SAPs or PPSs (109 +/- 31 cells/mm(2) and 108 +/- 60 cells/mm(2), respectively), when compared with preservation in Cl(-)-containing control or LB solutions (429 +/- 63 cells/mm(2) and 277 +/- 59 cells/mm(2)). In rat liver preservation, anionic polysaccharides are antiedematous compounds, with a higher potency than LB and additional antiadhesive properties.
Fukuda
Chifumi
C
Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.
Kollmar
Otto
O
Schäfer
Thilo
T
Tian
Ying-Hua
YH
Schilling
Martin K
MK
D000241:Adenosine / Q000032:analysis; D000493:Allopurinol / Q000032:analysis; D000818:Animals; D000838:Anions / Q000032:analysis / Q000627:therapeutic use; D002240:Carbohydrate Sequence; D004187:Disaccharides / Q000032:analysis / Q000627:therapeutic use; D005978:Glutathione / Q000032:analysis; D066298:In Vitro Techniques; D007328:Insulin / Q000032:analysis; D008099:Liver / Q000098:blood supply / Q000166:cytology / Q000187:drug effects* / Q000601:surgery; D008297:Male; D008856:Microscopy, Fluorescence; D018715:Microscopy, Video / Q000379:methods; D019188:Organ Preservation Solutions / Q000032:analysis* / Q000145:classification / Q000627:therapeutic use*; D010477:Perfusion; D011134:Polysaccharides / Q000032:analysis* / Q000627:therapeutic use*; D011887:Raffinose / Q000032:analysis; D051381:Rats; D011917:Rats, Inbred Lew; D017208:Rats, Wistar; D000267:Tissue Adhesions / Q000517:prevention & control*
D000838:Anions; D004187:Disaccharides; D007328:Insulin; D019188:Organ Preservation Solutions; D011134:Polysaccharides; C055206:University of Wisconsin-lactobionate solution; D000493:Allopurinol; C005608:lactobionic acid; D005978:Glutathione; D000241:Adenosine; D011887:Raffinose